Depletion of Bmi-1 enhances 5-fluorouracil-induced apoptosisand autophagy in hepatocellular carcinoma cells

Oncology Letters

Volumn 4, Issue 4, 2012, Pages 723-726

  Wu, Jing ^a   Hu, Dong ^a   Zhang, Rongbo ^a  

^a ANHUI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

5 fluorouracil; Apoptosis; Autophagy; B cell specific moloney murine leukemia virus insertion site 1; Hepatocellular carcinoma

Indexed keywords

BECLIN 1; BMI1 PROTEIN; FLUOROURACIL; MICROTUBULE ASSOCIATED PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B;

APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER GROWTH; CARCINOMA CELL; CHEMOSENSITIVITY; CONTROLLED STUDY; DRUG EFFECT; DRUG SENSITIVITY; GENE SILENCING; HUMAN; HUMAN CELL; IC 50; LIVER CELL CARCINOMA; PROTEIN DEPLETION; STATISTICAL SIGNIFICANCE;

EID: 84864704847     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.805     Document Type: Article

References (15)

1. Nagano H: Treatment of advanced hepatocellular carcinoma: intraarterial infusion chemotherapy combined with interferon. Oncology 78 (Suppl 1): 142-147, 2010.
2. LIovet JM and Bruix J: Molecular targeted therapies in hepatocellular carcinoma. Hepatology 48: 1312-1327, 2008.
3. Boulin M, Guiu S, Chauffert B, Aho S, Cercueil JP, Ghiringhelli F, Krause D, Fagnoni P, Hillon P, Bedenne L and Guiu B: Screening of anticancer drugs for chemoembolization of hepatocellular carcinoma. Anticancer Drugs 22: 741-748, 2011.
4. Haupt Y, Alexander WS, Barri G, Klinken SP and Adams JM: Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in E mu-myc transgenic mice. Cell 65: 753-763, 1991.
5. van Lohuizen M, Verbeek S, Scheijen B, Wientjens E, van der Gulden H and Berns A: Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging. Cell 65: 737-752, 1991.
6. Valk-Lingbeek ME, Bruggeman SW and van Lohuizen M: Stem cells and cancer; the polycomb connection. Cell 118: 409-418, 2004.
7. Gunster MJ, Raaphorst FM, Hamer KM, den Blaauwen JL, Fieret E, Meiier CJ and Otte AP: Differential expression of human polycomb group proteins in various tissues and cell types. J Cell Biochem Suppl 36: 129-143, 2001.
8. Wang H, Pan K, Zhang HK, Weng DS, Zhou J, Li JJ, Huang W, Song HF, Chen MS and Xia JC: Increased polycomb-group oncogene Bmi-1 expression correlates with poor prognosis in hepatocellular carcinoma. J Cancer Res Clin Oncol 134: 535-541, 2008.
9. Liu L, Andrews LG and Tollefsbol TO: Loss of the human polycomb group protein BMI1 promotes cancer-specific cell death. Oncogene 25: 4370-4375, 2006.
10. Wu J, Hu D, Yang G, Zhou J, Yang C, Gao Y and Zhu Z: Down-regulation of Bmi-1 cooperates with ar temisinin on growth inhibition of nasopharyngeal carcinoma cells. J Cell Biochem 112: 1938-1948, 2011.
11. Chipuk J E and Green DR: How do Bcl-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol 18: 157-164, 2008.
12. Whittaker S, Marais R and Zhu AX: The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene 29: 4989-5005, 2010.
13. Chen YL, Law PY and Loh HH: Inhibition of PI3K/Akt signaling: an emerging paradigm for targeted cancer therapy. Curr Med Chem Anticancer Agents 5: 575-589, 2005.
14. Gump JM and Thorburn A: Autophagy and apoptosis: what is the connection? Trends Cell Biol 21: 387-392, 2011.
15. Zhou F, Yang Y and Xing D: Bcl-2 and Bcl-xl play important roles in the crosstalk between autophagy and apoptosis. FEBS J 278: 403-413, 2011.